Literature DB >> 1899049

Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells.

C V Harding1, D S Collins, J W Slot, H J Geuze, E R Unanue.   

Abstract

Antigen processing requires intracellular antigen catabolism to generate immunogenic peptides that bind to class II MHC molecules (MHC-II) for presentation to T-cells. We now provide direct evidence that these peptides are produced within dense lysosomes, as opposed to earlier endocytic compartments. The protein antigen hen egg lysozyme was targeted to endosomes or lysosomes by encapsulating it in liposomes of different membrane composition. Acid-sensitive liposomes released their contents in early endosomes, whereas acid-resistant liposomes sequestered their contents from potential endosomal processing events and released their contents only after delivery to lysosomes. Antigen encapsulated in acid-resistant liposomes was processed in a chloroquine-sensitive manner and presented more efficiently than soluble antigen or antigen encapsulated in acid-sensitive liposomes. Thus, peptides may be recycled from lysosomes, transported to endosomes to bind MHC-II, and then expressed at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899049     DOI: 10.1016/0092-8674(91)90647-h

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  70 in total

1.  In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.

Authors:  C Sedlik; G Dadaglio; M F Saron; E Deriaud; M Rojas; S I Casal; C Leclerc
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine.

Authors:  A I Bot; D J Smith; S Bot; L Dellamary; T E Tarara; S Harders; W Phillips; J G Weers; C M Woods
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

4.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

5.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.

Authors:  C A Nelson; R W Roof; D W McCourt; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules.

Authors:  Toyoshi Matsutake; Tatsuya Sawamura; Pramod K Srivastava
Journal:  Cancer Immun       Date:  2010-08-02

7.  Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.

Authors:  J N Verma; M Rao; S Amselem; U Krzych; C R Alving; S J Green; N M Wassef
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 8.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

10.  Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

Authors:  Dapeng Zhou; Carlos Cantu; Yuval Sagiv; Nicolas Schrantz; Ashok B Kulkarni; Xiaoyang Qi; Don J Mahuran; Carlos R Morales; Gregory A Grabowski; Kamel Benlagha; Paul Savage; Albert Bendelac; Luc Teyton
Journal:  Science       Date:  2003-12-18       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.